We are a global biopharmaceutical company focused on human health. We help prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering.
Sanofi Genzyme is the speciality care global business unit of Sanofi, focused on immunology, multiple sclerosis, oncology, rare diseases and rare blood disorders.
In the UK, there are now an estimated 2.5 million people living with cancer. This is expected to rise to 4 million by 20301. Sanofi Genzyme Oncology believes that people with cancer and their healthcare providers deserve more – more options, more support, more life. We are working with healthcare professionals, people with cancer, advocates and policymakers to optimise cancer care and empower people.
1 https://www.macmillan.org.uk/_images/cancer-statistics-factsheet_tcm9-260514.pdf (accessed 05.03.2021)
Sanofi Genzyme are supporting this meeting through sponsorship and have had no control over the agenda, educational content or logistics of this event
MAT-GB-2100504(v1.0) | February 2021